Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ferdous Al-Faruque

Senior Reporter

Washington, DC

Ferdous Al-Faruque, known as Danny, specializes in reporting on new medical device technologies such as mobile health, combination products, unique device identifiers, and issues surrounding interoperability and cyber security. He is also our resident podcast expert, and has brought listeners the voices of top FDA officials as well as industry leaders. Danny is a big sci-fi fan, especially Battlestar Galactica and Star Trek. Qapla'!'}">Ferdous Al-Faruque, known as Danny, specializes in reporting on new medical device technologies such as mobile health, combination products, unique device identifiers, and issues surrounding interoperability and cyber security. He is also our resident podcast expert, and has brought listeners the voices of top FDA officials as well as industry leaders. Danny is a big sci-fi fan, especially Battlestar Galactica and Star Trek. Qapla'!

Latest From Ferdous Al-Faruque

New Material Safety Reports Highlight Lack Of Data To Fully Evaluate Adverse Reactions

The US FDA and ECRI released four reports about the safety of certain materials used in medical devices. While the risks seem to be comparatively low, they note the quality of literature is lacking to make broad evaluations.

Regulation FDA

New FDA Web Page Spotlights AI/ML Progress

The US agency has published a list of more than 300 artificial intelligence/machine learning devices it has allowed on the market, highlighting the work it has done to review these new and complicated products.

Artificial Intelligence Digital Health

Another Set Of Eyes: US FDA Authorizes AI Software To Spot Prostate Cancer

The Paige Prostate is a first-of-its-kind digital prostate imaging analysis software that can act as an extra pair of eyes to help pathologists spot cancer cells.

Commercial Regulation

DOD Contracts OraSure Rapid COVID-19 Tests For $205M

The US defense department’s Defense Logistics Agency will distribute the rapid antigen tests to 25,000 locations around the country to help stymie the spread of SARS-CoV-2 and its variants.

Diagnostics OTC Devices

Overflow Issue With Abbott COVID Tests Could Result In False Positives

The mixture in some faulty Abbott PCR tests could cause COVID-19 positive samples to flow into neighboring negative samples, resulting in false-positive results.

Regulation Commercial

New FDA Office Aims To Improve IT Interactions With Sponsors

The US agency’s new Office of Digital Transformation will aggregate a number of IT operations under one office to streamline the agency’s work, including its interactions with device sponsors.

FDA Policy
See All
UsernamePublicRestriction

Register